Product NDC: | 0024-5801 |
Proprietary Name: | Xyzal |
Non Proprietary Name: | levocetirizine dihydrochloride |
Active Ingredient(s): | .5 mg/mL & nbsp; levocetirizine dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-5801 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022157 |
Marketing Category: | NDA |
Start Marketing Date: | 20080402 |
Package NDC: | 0024-5801-15 |
Package Description: | 6 BOTTLE, GLASS in 1 CARTON (0024-5801-15) > 15 mL in 1 BOTTLE, GLASS |
NDC Code | 0024-5801-15 |
Proprietary Name | Xyzal |
Package Description | 6 BOTTLE, GLASS in 1 CARTON (0024-5801-15) > 15 mL in 1 BOTTLE, GLASS |
Product NDC | 0024-5801 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levocetirizine dihydrochloride |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20080402 |
Marketing Category Name | NDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |